FR88M - - Google Patents
Info
- Publication number
- FR88M FR88M FR834523A FR834523A FR88M FR 88 M FR88 M FR 88M FR 834523 A FR834523 A FR 834523A FR 834523 A FR834523 A FR 834523A FR 88 M FR88 M FR 88M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR834523A FR88M (es) | 1960-07-29 | 1960-07-29 | |
| GB26856/61A GB922361A (en) | 1960-07-29 | 1961-07-25 | Improvements in and relating to lysine orotate and its therapeutic applications |
| CH884561A CH394216A (fr) | 1960-07-29 | 1961-07-27 | Procédé de préparation d'orotate de lysine |
| BE606638A BE606638A (fr) | 1960-07-29 | 1961-07-27 | Orotate de lysine et ses applications thérapeutiques |
| US127154A US3161565A (en) | 1960-07-29 | 1961-07-27 | Lysine orotate |
| ES0269442A ES269442A1 (es) | 1960-07-29 | 1961-07-28 | Procedimiento de preparaciën de orotato de lisina |
| DK312061AA DK105811C (da) | 1960-07-29 | 1961-07-28 | Fremgangsmåde til fremstilling af lysinorotat. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR834523A FR88M (es) | 1960-07-29 | 1960-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR88M true FR88M (es) | 1961-01-09 |
Family
ID=8736588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR834523A Active FR88M (es) | 1960-07-29 | 1960-07-29 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3161565A (es) |
| BE (1) | BE606638A (es) |
| CH (1) | CH394216A (es) |
| DK (1) | DK105811C (es) |
| ES (1) | ES269442A1 (es) |
| FR (1) | FR88M (es) |
| GB (1) | GB922361A (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037488A2 (de) * | 1980-03-25 | 1981-10-14 | Hrvoje Dr. Krnjevic | Pharmazeutisches Mittel zur Heilung von entzündlichen und/oder degenerativen und/oder atrophischen Schleimhauterkrankungen |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470838A (en) * | 1987-10-28 | 1995-11-28 | Pro-Neuron, Inc. | Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine |
| US7776838B1 (en) | 1987-10-28 | 2010-08-17 | Wellstat Therapeutics Corporation | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| US5736531A (en) | 1987-10-28 | 1998-04-07 | Pro-Neuron, Inc. | Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
| US7173017B1 (en) * | 1987-10-28 | 2007-02-06 | Wellstat Therapeutics Corporation | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| MX9700109A (es) * | 1994-07-01 | 1997-04-30 | Pro Neuron Inc | Precursores nucleotidos de pirimidina para el tratamiento de inflamaciones sistemicas y hepatitis inflamatoria. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2556907A (en) * | 1950-01-27 | 1951-06-12 | Du Pont | Resolution of lysine |
| US2738299A (en) * | 1953-05-11 | 1956-03-13 | Abbott Lab | Stable nutritive amino acid compositions |
| US2802864A (en) * | 1953-09-01 | 1957-08-13 | Int Minerals & Chem Corp | Higher alkyl amine salts of glutamic acid |
| US2992163A (en) * | 1955-11-07 | 1961-07-11 | Lilly Co Eli | Use of 4-chloro-1, 2-pyrazole for controlling epileptic seizures |
| US2859244A (en) * | 1956-09-28 | 1958-11-04 | Dow Chemical Co | Resolution of dl-lysine with d-camphoric acid |
| US3020278A (en) * | 1959-09-16 | 1962-02-06 | Jr Edgar A Ferguson | Vitamin-orotic acid compositions |
| US3062722A (en) * | 1960-03-15 | 1962-11-06 | Garofalo Domenico | Therapeutic 2-aminoethanethiol orate |
-
1960
- 1960-07-29 FR FR834523A patent/FR88M/fr active Active
-
1961
- 1961-07-25 GB GB26856/61A patent/GB922361A/en not_active Expired
- 1961-07-27 US US127154A patent/US3161565A/en not_active Expired - Lifetime
- 1961-07-27 CH CH884561A patent/CH394216A/fr unknown
- 1961-07-27 BE BE606638A patent/BE606638A/fr unknown
- 1961-07-28 ES ES0269442A patent/ES269442A1/es not_active Expired
- 1961-07-28 DK DK312061AA patent/DK105811C/da active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037488A2 (de) * | 1980-03-25 | 1981-10-14 | Hrvoje Dr. Krnjevic | Pharmazeutisches Mittel zur Heilung von entzündlichen und/oder degenerativen und/oder atrophischen Schleimhauterkrankungen |
| EP0037488A3 (en) * | 1980-03-25 | 1982-11-24 | Hrvoje Dr. Krnjevic | Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes |
Also Published As
| Publication number | Publication date |
|---|---|
| BE606638A (fr) | 1961-11-16 |
| GB922361A (en) | 1963-03-27 |
| US3161565A (en) | 1964-12-15 |
| DK105811C (da) | 1966-11-14 |
| CH394216A (fr) | 1965-06-30 |
| ES269442A1 (es) | 1962-01-01 |